Entrada Therapeutics, Inc. Common Stock (TRDA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TRDA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 125 institutions reported holding TRDA, with 29.1 million shares worth $214.4 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Baker Bros. Advisors | 5,072,730 | $37M | UNCHANGED |
| 5am Venture Management | 4,056,379 | $30M | UNCHANGED |
| BlackRock | 2,583,333 | $19M | INCREASED |
| Merck & Co | 1,739,768 | $13M | NEW |
| Vanguard | 1,700,222 | $13M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Entrada Therapeutics, Inc. Common Stock on SentiSense.